We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$10.8B
AUM Growth
-$222M
Cap. Flow
-$287M
Cap. Flow %
-2.66%
Top 10 Hldgs %
9.23%
Holding
920
New
57
Increased
332
Reduced
337
Closed
91

Top Buys

Rank Stock Value
1
LCII icon
LCI Industries
LCII
+$19.9M
2
KWR icon
Quaker Houghton
KWR
+$19.1M
3
FORM icon
FormFactor
FORM
+$17.5M
4
AMSF icon
AMERISAFE
AMSF
+$16.5M
5
TKR icon
Timken Company
TKR
+$16.3M

Sector Composition

Rank Sector Weight
1 Industrials 25.23%
2 Technology 19.83%
3 Financials 14.91%
4 Consumer Discretionary 12.13%
5 Healthcare 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPOP icon
176
Popular Inc
BPOP
$11B
$17.8M 0.17%
189,632
RELL icon
177
Richardson Electronics
RELL
$244M
$17.5M 0.16%
1,248,276
+119,685
+11% +$1.66M
SHOE
178
Shoe Station Group
SHOE
$424M
$17.5M 0.16%
528,092
+64,239
+14% +$2.33M
LMB icon
179
Limbach Holdings
LMB
$807M
$17.3M 0.16%
202,470
-47,108
-19% -$4.15M
FN icon
180
Fabrinet
FN
$14.9B
$17.3M 0.16%
78,701
-90,683
-54% -$21.9M
GHM icon
181
Graham Corp
GHM
$1.03B
$17.3M 0.16%
388,024
-39,274
-9% -$1.47M
HLI icon
182
Houlihan Lokey
HLI
$9.72B
$17.2M 0.16%
99,168
-23,288
-19% -$4.1M
CBZ icon
183
CBIZ
CBZ
$2.95B
$17.1M 0.16%
208,919
+13,738
+7% +$1.03M
CORT icon
184
Corcept Therapeutics
CORT
$9.98B
$17M 0.16%
338,300
-24,972
-7% -$1.31M
ATEN icon
185
A10 Networks
ATEN
$2.07B
$16.9M 0.16%
919,068
+76,412
+9% +$1.25M
CLB icon
186
Core Laboratories
CLB
$455M
$16.8M 0.16%
969,128
-51,993
-5% -$1M
ETD icon
187
Ethan Allen Interiors
ETD
$600M
$16.6M 0.15%
590,993
+276,534
+88% +$8.2M
DNB
188
DELISTED
Dun & Bradstreet
DNB
$16.5M 0.15%
1,328,160
-318,446
-19% -$3.81M
WNC icon
189
Wabash National
WNC
$504M
$16.5M 0.15%
963,367
-282,693
-23% -$5.24M
PLAB icon
190
Photronics
PLAB
$1.65B
$16.4M 0.15%
696,828
-49,778
-7% -$1.22M
SIG icon
191
Signet Jewelers
SIG
$3.84B
$16.3M 0.15%
202,280
+9,559
+5% +$890K
BCML icon
192
BayCom
BCML
$335M
$16.2M 0.15%
603,286
+60,075
+11% +$1.59M
RGP icon
193
Resources Connection
RGP
$140M
$16.1M 0.15%
1,891,461
-6,108
-0.3% -$51.5K
AIR icon
194
AAR Corp
AIR
$5.4B
$16.1M 0.15%
263,180
+19,620
+8% +$1.26M
BWXT icon
195
BWX Technologies
BWXT
$14.4B
$16.1M 0.15%
144,564
-9,050
-6% -$1.11M
RNGR icon
196
Ranger Energy Services
RNGR
$356M
$16.1M 0.15%
1,038,772
+56,774
+6% +$814K
FHI icon
197
Federated Hermes
FHI
$4.56B
$16M 0.15%
390,395
-837
-0.2% -$33.8K
MTDR icon
198
Matador Resources
MTDR
$6.04B
$16M 0.15%
284,845
-72,718
-20% -$4M
NTB icon
199
Bank of N.T. Butterfield & Son
NTB
$2.41B
$16M 0.15%
438,003
-21,867
-5% -$818K
POWL icon
200
Powell Industries
POWL
$6.79B
$16M 0.15%
216,579
-6,795
-3% -$607K

Similar funds

Royce & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Royce & Associates held 920 positions worth $10.8B, down 2% from $11B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

Royce & Associates's Q4 2024 filing shows 57 new, 332 increased, 337 reduced and 91 closed positions. Its largest new stake was AMERISAFE: 305,361 shares worth $15.7M. The largest sale was Ziff Davis, an estimated $33.8M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q4 2024 buy was AMERISAFE: 305,361 shares worth $15.7M.
  • Royce & Associates added most to LCI Industries in Q4 2024, an estimated $19.9M increase.
  • Royce & Associates's biggest Q4 2024 reduction was Ziff Davis, cutting an estimated $33.8M.
  • Royce & Associates fully exited Carter's in Q4 2024, selling an estimated $13.1M.
  • Royce & Associates's ten largest holdings make up 9.2% of its $10.8B portfolio in Q4 2024.
  • Royce & Associates opened 57 new positions and closed 91 in Q4 2024.
  • Royce & Associates's portfolio value fell 2% quarter-over-quarter to $10.8B.

Based on Royce & Associates's 13F filing for Q4 2024, filed 10 Feb 2025.